Cargando…
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis
OBJECTIVES: Cytokine release syndrome with elevated interleukin-6 (IL-6) levels is associated with multiorgan damage and death in severe coronavirus disease 2019 (COVID-19). Our objective was to perform a living systematic review of the literature concerning the efficacy and toxicity of the IL-6 rec...
Autores principales: | Tleyjeh, Imad M., Kashour, Zakariya, Damlaj, Moussab, Riaz, Muhammad, Tlayjeh, Haytham, Altannir, Mustafa, Altannir, Youssef, Al-Tannir, Mohamad, Tleyjeh, Rana, Hassett, Leslie, Kashour, Tarek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644182/ https://www.ncbi.nlm.nih.gov/pubmed/33161150 http://dx.doi.org/10.1016/j.cmi.2020.10.036 |
Ejemplares similares
-
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update
por: Tleyjeh, Imad M., et al.
Publicado: (2021) -
Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis – Author’s reply
por: Kashour, Tarek, et al.
Publicado: (2021) -
Association of corticosteroids use and outcomes in COVID-19 patients: A systematic review and meta-analysis
por: Tlayjeh, Haytham, et al.
Publicado: (2020) -
Mortality, viral clearance, and other clinical outcomes of hydroxychloroquine in COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Kashour, Zakariya, et al.
Publicado: (2021) -
Cardiac Toxicity of Chloroquine or Hydroxychloroquine in Patients With COVID-19: A Systematic Review and Meta-regression Analysis
por: Tleyjeh, Imad M., et al.
Publicado: (2020)